Holen Sie sich die Stockscreener-App
3.02
2.89%
-0.09
Handel nachbörslich:
2.99
-0.03
-0.99%
Compass Therapeutics Inc Aktie (CMPX) Neueste Nachrichten
Compass Therapeutics stock hits 52-week high at $3.14 - MSN
Biliary Tract Cancer Market Poised for Significant Growth from - openPR
Compass Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference - GlobeNewswire
Compass Therapeutics stock hits 52-week high at $3.14 By Investing.com - Investing.com South Africa
Nike Inc (NKE-N) QuotePress Release - The Globe and Mail
Can Compass Therapeutics' Tovecimig Chart A New Direction In The Treatment Of Biliary Tract Cancers? - RTTNews
Is Compass Therapeutics, Inc. (CMPX) the Hottest Smid-Cap Stock So Far In 2025? - Insider Monkey
Compass Therapeutics, Inc. (NASDAQ:CMPX) Sees Significant Growth in Short Interest - Defense World
Short Interest in Compass Therapeutics, Inc. (NASDAQ:CMPX) Grows By 5.2% - MarketBeat
Compass Therapeutics, Inc. (NASDAQ:CMPX) Shares Acquired by Barclays PLC - Defense World
Barclays PLC Purchases 112,614 Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX) - MarketBeat
2025 catalysts: Bispecifics poised to enter new era - BioCentury
Compass Therapeutics, Inc. (NASDAQ:CMPX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Denali Therapeutics (NASDAQ:DNLI) Earns “Outperform” Rating from William Blair - Defense World
VerifyMe (NASDAQ: VRME) Enters Agreement with Institutional Investor for $4.7 Million Proceeds - Defense World
Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
Cantor Fitzgerald Reaffirms Overweight Rating for Amicus Therapeutics (NASDAQ:FOLD) - Defense World
Alliance Global Partners Initiates Coverage on TMC the metals (NASDAQ:TMC) - Defense World
Compass Therapeutics stock hits 52-week high at $2.68 - MSN
TANG CAPITAL MANAGEMENT LLC Increases Stake in Compass Therapeutics Inc - GuruFocus.com
Compass Therapeutics stock hits 52-week high at $2.68 By Investing.com - Investing.com UK
Investors Eye Biotech Stocks as Cancer Therapies Take Center Stage in 2025 - Baystreet.ca
Jane Street Group LLC Trims Stock Holdings in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World
Biliary Tract Cancer Market Expected to Experience Major Growth - openPR
Pre-market Movers: ONCO, EYEN, SGMO, VSTM... - RTTNews
D. Boral Capital Reiterates “Buy” Rating for Compass Therapeutics (NASDAQ:CMPX) - Defense World
Compass Therapeutics (NASDAQ:CMPX) Earns Buy Rating from HC Wainwright - Defense World
Ampio Pharmaceuticals (NYSE:AMPE) Now Covered by StockNews.com - Defense World
Amplitude Healthcare Acquisition (OTCMKTS:AMHCU) Announces Positive Preliminary Data from Jasper Therapeutics, Inc. BEACON Phase 1b/2a StudyOn January 8, 2025, Jasper Therapeutics, Inc. released a press release detailing encouraging preliminar - Defense World
Windtree Therapeutics Announces New Corporate Strategy in Recent Press Release - Defense World
KBW Regional Banking Index (KRX) QuotePress Release - The Globe and Mail
Nasdaq Financial 100 Index (IXF) QuotePress Release - The Globe and Mail
Compass Therapeutics Provides Corporate Update and Announces Advancement of a New Drug Candidate - GlobeNewswire
Another Day, Another Biotech Stealing The Show - MSN
Nasdaq Industrial Index (INDS) QuotePress Release - The Globe and Mail
TSX High Income Energy USD Index (TXHU) QuotePress Release - The Globe and Mail
TSX Health Care Capped Index (TTHC) QuotePress Release - The Globe and Mail
TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail
Stock Market Movers Today • Top Gainers & Losers - Benzinga
KBW Finsec Dividend Yield Index (KDX) QuotePress Release - The Globe and Mail
CMPX stock touches 52-week high at $2.35 amid market fluctuations - Investing.com Canada
Compass Therapeutics' (CMPX) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
D. Boral Capital Reaffirms "Buy" Rating for Compass Therapeutics (NASDAQ:CMPX) - MarketBeat
Compass Therapeutics reports progress on cancer treatments - Investing.com
US Penny Stocks To Watch In January 2025 - Simply Wall St
Geode Capital Management LLC Buys 128,655 Shares of FutureFuel Corp. (NYSE:FF) - Defense World
Golden Entertainment, Inc. (NASDAQ:GDEN) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Geode Capital Management LLC Acquires 19,095 Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World
Geode Capital Management LLC Lowers Stock Holdings in ON24, Inc. (NYSE:ONTF) - Defense World
Geode Capital Management LLC Raises Holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Tucows Inc. (NASDAQ:TCX) Shares Bought by Barclays PLC - Defense World
Geode Capital Management LLC Grows Stock Holdings in BARK, Inc. (NYSE:BARK) - Defense World
Geode Capital Management LLC Has $4.76 Million Stock Position in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World
Geode Capital Management LLC Buys 1,957 Shares of Tile Shop Holdings, Inc. (NASDAQ:TTSH) - Defense World
Geode Capital Management LLC Sells 8,363 Shares of MacroGenics, Inc. (NASDAQ:MGNX) - Defense World
5.49%
0.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):